Alector Inc ALEC

$1.81 -0.05 (-2.69%)

Valuation

Market cap
207,682,000
Revenue TTM
$21,050,000
Net income TTM
$-142,930,000
PE ratio
0.00
Forward PE
—
Profit margin
-679.00%
Debt to equity
-0.99

Trading

Volume
1,170,900
Avg volume
1,335,966
Day's range
$1.80 – $1.97
Shares out
111,657,000
Stochastic %K
4%
Beta
0.62
Analysts
Sell
Price target
$3.10

Price

Company profile

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL0...

Show more

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.

Industry
Biotechnology
Sector
Healthcare
Phone
415 231 5660
Website
https://www.alector.com
Address
131 Oyster Point Boulevard, Suite 600, South San Francisco, United States

Latest news

Stocktwits

BiotechButterflies Sep 10, 4:42 PM
$ALEC ... hoping for a good performance at Cantor Fitz.... cool early stage assets... hanging in for a bit more....
0 replies
CC123italy Sep 2, 7:54 PM
$ALEC definitely looks like something is happening 👀
0 replies
CC123italy Sep 2, 7:52 PM
$ALEC 🚀🚀🚀
0 replies
kshonstocks Aug 18, 4:34 PM
$ALEC 1.5 M block went through
1 replies
GSP Aug 12, 11:54 AM
$FRMI $ACHR $ALEC $LASR $CRSR
0 replies
GSP Aug 11, 9:21 PM
Your Day Trading Watch List Video for August 12th in About 3 Minutes (con't): $FRMI $ACHR $ALEC $LASR $CRSR .
0 replies
manymore Aug 11, 4:52 PM
$ALEC just one more intriguing spike ...
0 replies
CamilaCruze Aug 8, 2:16 AM
$ALEC on my watchlist 4 next week
1 replies